Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12622000862741Phase 3Recruiting
Phase 3, randomised, double-blind trial in delirium comparing Fluvoxamine with Placebo (2 arms). Primary endpoint: Feasibility: eligible participants enrolled per month. Started Sep 2023; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12622000862741.